Drug development

Handshake jigsaw puzzle
#Cancer #Clinical trials #Drug development #Paediatrics

Advancing paediatric cancer research through partnerships 

Paediatric oncologist Gauri Sunkersett shares her unique background and research approach at AbbVie to help find answers for the youngest blood cancer patients.   When I was a second-year resident training as a paediatric oncologist at Nicklaus Children’s Hospital, I met a teenage boy diagnosed with Hodgkin’s Lymphoma. He was admitted… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Collaboration #Drug development #Drug discovery #Partnership

Key industry partnerships advancing drug discovery

Otsuka Pharmaceutical and Ionis Pharmaceuticals Otsuka Pharmaceutical and RNA therapy company Ionis have entered into a licence agreement for Otsuka to acquire exclusive marketing rights to Ionis' hereditary angioedema (HAE) drug candidate donidalorsen in Europe. Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein, or PKK,… Read More

#Business & Investment #News

384-well microplate
#Assays #Aurora Microplates #Drug development #Drug discovery #Lab technology #Podcast #Preclinical development

Podcast: How the tools you use impact precision in the lab

The latest sponsored DDW Sitting Down With podcast is now available. It features Charles Powell, CEO of Aurora Microplates, discussing how the Aurora microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has… Read More

#News

384-well microplate
#Assays #Aurora Microplates #Drug development #Drug discovery #Lab technology #Preclinical development

How the tools you use impact consistency and precision in the lab

The latest sponsored DDW Sitting Down With podcast features Charles Powell, CEO of Aurora Microplates, discussing how the microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has a crucial role to play… Read More

#Podcasts

#Drug development #Drug discovery #Guide #Human disease models #Mouse models #Pharmokinetics

HuPK: A Humanised Platform for therapeutic antibody PK evaluation

Download the guide to learn more about:   How JAX’s HuPK™ Humanised FcRn Platform offers a validated and cost-effective solution for assessing the in vivo  preclinical pharmacokinetics and stability of Fc-based biologics and therapeutics carried by albumin.    JAX’s… Read More

#Intelligence #Resources

#Drug delivery #Drug development #Drug discovery #Drug repurposing #Microbiome #Mucoadhesive drug delivery #Pharmaceutical industry #Synthetic biology

New podcast: Outside the box thinking for drug discovery success

This is the latest episode of the free DDW narrated podcast, “Outside the box thinking for drug discovery success”, which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Stanford researchers construct the most complete synthetic microbiome, … Read More

#News

#Biomedical research #Drug development #Meet the Researcher #Pathology #Virscio

Meet the researcher: Jennifer Cann, Virscio 

DDW’s Megan Thomas speaks to Jennifer Cann, Director of Pathology at Virscio, a company solving human health challenges through biomedical research.  MT: Can you provide a top line summary of your research? JC: As Virscio’s Director of Pathology, I provide exploratory and translational pathology support for drug development research at… Read More

#Exclusive Content #Opinion

Two scientists working in a lab
#Antibody discovery workflow #Biotherapeutics #Cell line development #Cell lines #Drug development #Large molecules

Advancements in upstream CLD for enhanced biotherapeutics production

This article is sponsored by Revvity. By Anis H Khimani, PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. As the significance of large molecules continues to broaden across diverse modalities, emphasis… Read More

#Exclusive Content

#Data #Drug development #Drug discovery #Sustainability

Pistoia Alliance sets out strategic priorities in key areas of R&D  

The Pistoia Alliance has announced four new strategic priorities that will enable the not-for-profit group to accelerate key areas within R&D.  The Pistoia Alliance has appointed steering committees to lead collaboration in the areas of sustainability, adoption of AI, the use of real-world data and data-driven value. Read More

#News

Cytometry
#Drug development #Drug discovery #Mass cytometry #Phenotyping #Preclinical development

Digital Article: Immunophenotyping for targeted drug discovery

A new digital article is now available to download entitled ‘A comprehensive approach to immunophenotyping for targeted drug discovery and development’.  With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies. Download this content-rich digital article to read… Read More

#News

#Drug development #Drug discovery #Mass cytometry #Phenotyping #Preclinical development

A comprehensive approach to immunophenotyping for targeted drug discovery and development

With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies. Download this content-rich digital article to read about considerations for implementing and standardising high-dimensional immune profiling methods into drug development programs. Learn about different applications that demonstrate the robustness and reproducibility of a mass cytometry-based… Read More

#Resources

Samples for chemical analysis
#Bioseparation #Characterisation #Drug development #Drug discovery #LC-MS #Mass spectrometry / NMR

New whitepaper: Unlock hidden isomers in your LC-MS analysis

Feeling isomer FOMO? Download this new whitepaper from MOBILion Systems ‘High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)’. MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of… Read More

#News

#Bioseparation #Characterisation #Drug development #Drug discovery #LC-MS #Mass spectrometry / NMR

Isomer FOMO? Unlock hidden isomers in your LC-MS analysis

MOBILion Systems is pioneering the evolution of separation science. High-resolution ion mobility (HRIM) on the MOBIE platform offers deeper, more accurate, and efficient characterisation of complex molecules than traditional methods. Download the whitepaper “High-Throughput Monitoring of Biotherapeutic Critical Quality Attributes with High-Resolution Ion Mobility-Mass Spectrometry (HRIM-MS)” to learn more about:… Read More

#Resources

International Space Station (ISS)
#Drug development #Drug discovery #Eli Lilly #Lab space #Pharmaceuticals #Redwire

First spaceflight mission for drug development lab

Redwire will launch its in-space pharmaceutical manufacturing platform, PIL-BOX, onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS). The platform is designed to offer pharmaceutical companies and researchers novel and flexible services to grow small-batch crystals of protein-based pharmaceuticals… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Life science #Life sciences #Market reporting #TechBio #UK

‘Life Sciences Future50’ shines light on UK innovation

PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. According to the report, the life science industry represents a £43.4 ($52.7) billion annual contribution to GVA and supports 646,000… Read More

#News #Trending News #Trends & Analysis